Key result
Point-of-care INR testing shows excellent correlation with lab analyzers but supratherapeutic bias may affect dosing.
Why the study?
Does a POCT coagulometer provide reliable INR measurements compared to a standard laboratory analyzer for dosing decisions in outpatients on oral anticoagulants?
Observational (n=200)
Does a POCT coagulometer provide reliable INR measurements compared to a standard laboratory analyzer for dosing decisions in outpatients on oral anticoagulants?
Answers are grounded in this paper and cite their sources.
POCT coagulometers show excellent overall agreement with standard laboratory analyzers for INR monitoring, but positive bias in the supratherapeutic range may require laboratory confirmation for dosing decisions.
Point-of-care testing (POCT) coagulometers are increasingly being used in the hospital setting and patients' self-testing. We determined the agreement of prothrombin time international normalized ratio (INR) results by POCT coagulometer and laboratory instrument through a comparative analysis and investigated whether the results of POCT coagulometer can reliably be used without being confirmed by standard laboratory analyzer. A total of 200 INR measurements by POCT coagulometer (CoaguChek XS Pro) and laboratory analyzer (Sysmex CS2000i) were compared using Passing-Bablok regression analysis and Bland-Altman plot. Agreement of the INR measurement was further analyzed in relation to dosing decision. The correlation of INR measurements between CoaguChek XS Pro and Sysmex CS2000i was excellent (correlation coefficient = 0.973). The overall mean difference was 0.21 INR ± 0.32 (range: 1.7-0.44). The mean difference was found to get increased as INR results increased and was 0.09 in the subtherapeutic range (≤1.9 INR), 0.29 INR in the therapeutic range (2.0-3.0 INR), while 0.4 INR in the supratherapeutic range (>3.0 INR). The overall agreement was excellent (κ = 0.916) and overall 11 (5.5%) of 200 INR measurements showed a difference in dosing decision between the 2 instruments. The positive bias of POC-INR is evident in the supratherapeutic range which could affect the dosing decision requiring confirmation with the laboratory INR measurement.
No takes yet. Share an insight, caveat, or question.
Moiz et al. (2018) conducted an observational in Oral anticoagulant therapy (n=200). POCT coagulometer (CoaguChek XS Pro) vs. Laboratory analyzer (Sysmex CS2000i) was evaluated on Agreement of prothrombin time INR results (MD 0.21). Point-of-care INR testing using CoaguChek XS Pro showed excellent correlation with standard laboratory analyzers, though a positive bias in the supratherapeutic range may affect dosing.
Synapse has enriched 10 related papers. Consider them for comparative context: